Chicago Capital, LLC’s Ligand Pharmaceuticals Inc Position
Does Chicago Capital, LLC own Ligand Pharmaceuticals Inc (LGND)? Yes — 561.7K shares worth $112M (+3.02% of its 13F portfolio) as of Q1 2026, up from 561.4K shares the prior filed quarter.
Position Value
$112M
Q1 2026
Shares
561.7K
% of Portfolio
+3.02%
Quarters Held
24
currently held
Position History LGND
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 561.7K | $112M | +3.02% |
| Q4 2025 | 561.4K | $106M | +2.62% |
| Q3 2025 | 568.6K | $101M | +2.48% |
| Q2 2025 | 571.8K | $65M | +1.60% |
| Q1 2025 | 554.5K | $58M | +1.65% |
| Q4 2024 | 551.6K | $59M | +1.57% |
| Q3 2024 | 545.8K | $55M | +1.52% |
| Q2 2024 | 514.9K | $43M | +1.29% |
| Q1 2024 | 229.6K | $17M | +0.51% |
| Q4 2023 | 231.5K | $17M | +0.60% |
| Q3 2023 | 360.3K | $22M | +1.01% |
| Q2 2023 | 424.0K | $31M | +1.38% |
| Q1 2023 | 449.5K | $33M | +1.65% |
| Q4 2022 | 319.1K | $21M | +1.18% |
| Q3 2022 | 459.3K | $40M | +2.29% |
| Q2 2022 | 448.4K | $40M | +2.21% |
| Q1 2022 | 491.7K | $55M | +2.38% |
| Q4 2021 | 436.5K | $67M | +2.51% |
| Q3 2021 | 440.3K | $61M | +2.33% |
| Q2 2021 | 459.0K | $60M | +2.35% |
| Q1 2021 | 448.6K | $68M | +2.89% |
| Q4 2020 | 332.9K | $33M | +1.48% |
| Q3 2020 | 485.8K | $46M | +2.38% |
| Q2 2020 | 268.8K | $30M | +1.74% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Chicago Capital, LLC’s full portfolio or all institutional holders of LGND.